International Stem Cell (ISCO) Share-based Compensation (2010 - 2026)
International Stem Cell (ISCO) posted Share-based Compensation of $59,000 for Q2 2026, down 3.3% from $61,000 a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Share-based Compensation (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at International Stem Cell was $247,000, down 31.6% year-over-year; for FY2025, it was $288,000, down 38.2% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of -25.8% (FY2020 to FY2025).
- In prior years, International Stem Cell's Share-based Compensation was $466,000 in FY2024 (+0.4%), $464,000 in FY2023 (+16.3%), $399,000 in FY2022 (-38.0%) and $644,000 in FY2021 (-49.6%).
- The Q2 2026 figure stands as the lowest quarterly Share-based Compensation since Q3 2013.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q1 2024, with growth of 26.9%; the weakest was Q1 2022, with a decline of 61.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 249.00 Mn |
| 10 | International Stem Cell | 2.08 Mn | -1.89 Mn | 1.46 Mn | 59,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59,000.00 |
| Dec 31, 2025 | 64,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Mar 31, 2024 | 137,000.00 |
| Dec 31, 2023 | 130,000.00 |
| Sep 30, 2023 | 118,000.00 |
| Jun 30, 2023 | 108,000.00 |
| Mar 31, 2023 | 108,000.00 |
| Dec 31, 2022 | 109,000.00 |
| Sep 30, 2022 | 109,000.00 |
| Jun 30, 2022 | 90,000.00 |
| Mar 31, 2022 | 91,000.00 |
| Dec 31, 2021 | 120,000.00 |
| Sep 30, 2021 | 118,000.00 |
| Jun 30, 2021 | 172,000.00 |
API Access
International Stem Cell Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();